Disrupted nitric oxide signaling due to GUCY1A3 mutations increases risk for moyamoya disease, achalasia and hypertension.

TitleDisrupted nitric oxide signaling due to GUCY1A3 mutations increases risk for moyamoya disease, achalasia and hypertension.
Publication TypeJournal Article
AuthorsWallace, S, Guo, D-C, Regalado, E, Mellor-Crummey, L, Bamshad, M, Nickerson, DA, Dauser, R, Hanchard, N, Marom, R, Martin, E, Berka, V, Sharina, I, Ganesan, V, Saunders, D, Morris, SA, Milewicz, DM
PubMed ID26777256
PubMed Central IDPMC4949143
Grant ListU54 HG006493 / HG / NHGRI NIH HHS / United States
R01 HL062594 / HL / NHLBI NIH HHS / United States
UL1 RR024148 / RR / NCRR NIH HHS / United States
UM1 HG006493 / HG / NHGRI NIH HHS / United States
P01 HL110869 / HL / NHLBI NIH HHS / United States
R01 HL109942 / HL / NHLBI NIH HHS / United States